Illumina Ventures
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- HQ
- CA
Illumina Ventures is a genomics and precision health investor that backs early-stage companies working to improve human health. The firm has a team of partners, principals, venture partners, and associates.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Growth, Series B |
| Sectors | Digital health, Biotech, Life sciences and research tools, Agtech, Synthetic biology | Not enough dated deals | Biotech, Healthtech, Life sciences and research tools, Medical devices |
| Regions | Not stated | Not enough dated deals | CA, NY |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2015 | 2 | Biotech, Consumer, Healthtech |
| 2016 | 3 | Biotech, Healthtech, Advanced materials |
| 2017 | 4 | Biotech, Healthtech, Life sciences and research tools |
| 2018 | 9 | Biotech, Healthtech, Life sciences and research tools |
| 2019 | 6 | Biotech, Healthtech, Life sciences and research tools |
| 2020 | 6 | Biotech, Healthtech, Life sciences and research tools |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2015 | 0 | 0 | 1 | 0 | 1 |
| 2016 | 0 | 0 | 0 | 1 | 1 |
| 2017 | 0 | 0 | 2 | 1 | 0 |
| 2018 | 0 | 0 | 4 | 2 | 1 |
| 2019 | 0 | 0 | 1 | 1 | 1 |
| 2020 | 0 | 0 | 1 | 2 | 3 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Illumina Innovation Fund III, L.P. Illumina Ventures is a genomics and precision health venture firm backing early-stage companies to improve human health. It invests across life sciences tools, diagnostics, therapeutics, digital health, and sustainability, including gene editing, cell and gene therapies, single cell analysis, and agricultural biotechnology. Inferred from the firm's website | 2024 | $60M to $200M (Form D) | Open, writing first checks |
| Illumina Innovation Fund II, L.P. | 2020 | $120.58M to $350M (Form D) | Follow-ons only |
03 · People across funds
- Nicholas Naclerio, Managing Member of the General Partner
Illumina Innovation Fund III, L.P. (Named on Form D); Illumina Innovation Fund II, L.P. (Named on Form D)
- Abhijit “Ron” Mazumder, Ph.D., Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Charles White, Ph.D., Principal
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Mara Aspinall, Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Nick Naclerio, Ph.D., Founding Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Tom Willis, Ph.D., Venture Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- William Byrne, Ph.D., Senior Associate
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Wouter Meuleman, Ph.D., Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Yuling Luo, Ph.D., Venture Partner
Illumina Innovation Fund III, L.P. (Team); Illumina Innovation Fund II, L.P. (Team)
- Abhijit "Ron" Mazumder, Ph.D., Partner
On the team page, not linked to a fund
- David C. Duffy, Ph.D., Entrepreneur in Residence
On the team page, not linked to a fund
- Ivan Coulter, Ph.D., Venture Advisor
On the team page, not linked to a fund
- Malek Faham, M.D., Ph.D., Chief Scientist
On the team page, not linked to a fund
- Martin Moorhead, Ph.D., Chief AI Scientist
On the team page, not linked to a fund
- Ronan Byrne, Venture Advisor
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- HTTP://WWW.ILLUMINAVENTURES.COM
- https://www.illuminaventures.com/contact/
- https://www.illuminaventures.com/team/
- https://www.illuminaventures.com/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026